This is your invitation to contribute to this strategy, an informal consultation project to surface tensions and disconnects, as well as connections and co-development opportunities.
I am not a clinician. What I bring to this draft strategy is something the health system has too rarely made space for: the experiences of living in a higher-weight body in a healthcare culture that has long treated that body as a problem to be fixed.
But this strategy development is not just from my story. It is built from more than a decade of conversations with hundreds of people and organisations who share similar experiences - patients who have left appointments feeling ashamed rather than supported; carers who have watched loved ones delay seeking help because they worried their concerns would be dismissed; citizens who have learned, over years, that the scales in the consultation room matter more than how they are actually functioning.
It comes too from the healthcare professionals already working differently - often with real skill, and often with real frustration - trying to provide good care within policies that keeps pointing them back to body weight.
What does weight-neutral practice mean? It means not making body weight the lens through which health is understood, and not making weight loss the target through which health is pursued.
It means focusing on the things that genuinely support health - like equitable access to nutritious food, opportunities to move in ways people enjoy, good sleep, manageable stress, and trusting and collaborative relationships with healthcare services - for everyone, at every size - whether they plan to attempt weight change or not.
The people whose voices shaped this strategy told us, in many different ways, the same thing: they want to be seen as whole people. They want to talk about how they feel, what they can, and already, do, and what gets in the way - not to be handed a referral to “weight management” and sent away. They described missing smear tests, putting off knee pain, avoiding their GP for years - not because they did not care about their health, but because the experience of seeking healthcare had taught them to expect judgement rather than help. That is a policy failure of the system; the metrics fail us all - the workforce and citizens alike.
The healthcare professionals we’ve spoken with are uncomfortable with the tools they are being asked to use. They know weight is a blunt measure. Knowing it does not tell them what they need to know about the people sitting in front of them. But the system keeps sending the same signal: measure weight, refer for weight-loss, repeat.
This strategy is about changing that signalling. To stop propping up diet culture. When we stop using body weight as the organising principle for health, we give clinicians the freedom to ask better health questions. We make space for the kind of healthcare that actually builds trust, equity, health literacy and engagement - without surveilling weight.
Mrs Helen James - Founder VCSE Nutriri
The UK's approach to higher-weight bodies has been built on a flawed premise: that weight = health, and that changing weight is sustainable and changes health. Sixty years of policy designed on this basis has not reduced population body weight, has not improved population health, and has generated considerable negative impacts on the people it was intended to help - particularly those already facing the greatest health inequalities (Ref. 37, 2025); (Ref. 68, 2025).
This is not a failure of effort. It is a failure of framework.
This Higher Weight Health Strategy (HWHS) proposes a simple but significant reorientation: that health services for people in higher-weight bodies and across the weight spectrum, should be designed, delivered, and measured around health outcomes - not weight outcomes. This shift does not require new staff, new buildings, or new budgets. It requires a change in what we signal, what we measure, and what we value.
The evidence base for this reorientation is substantial and growing. Beneficial behaviours improve health outcomes across all BMI categories, with some of the greatest gains observed in people classified as "obese" (Ref. 34, 2012). Modest concurrent improvements in sleep, physical activity, and nutrition are associated with meaningful gains in both lifespan and healthspan, regardless of weight change (Ref. 28, 2026).
Weight-inclusive interventions consistently deliver equal or better physical and psychological outcomes than weight-focused ones, with significantly lower dropout rates (Ref. 14, 2024). Meanwhile, healthy life expectancy in the UK has fallen to its lowest level since records began in 2011, and is declining in every region and every nation (Ref. 50, 2026) - under the watch of a weight-centric system.
Weight stigma is not a secondary concern. It is a structural driver of health inequality in its own right. It reduces healthcare engagement, erodes clinical trust, produces diagnostic overshadowing, and compounds existing inequalities of deprivation, ethnicity, gender, and disability (Ref. 61, 2018); (Ref. 54, 2015).
This HWHS sets out a weight-neutral triage framework that ensures equitable access to health support regardless of whether an individual is attempting weight loss, has a history of disordered eating or an eating disorder, has had or is awaiting bariatric surgery, is contraindicated for or declining medication risks, or is living with single or multiple long-term conditions. It replaces BMI as a gatekeeping criterion with health need and beneficial behavioural support. It replaces weight as an outcome measure with clinically meaningful markers of health and function.
The strategy has been developed by Nutriri, a VCSE organisation founded and led by a Patient Innovator, drawing on more than ten years of gathered lived experiences from citizens and the healthcare workforce across the UK, and grounded in the best available peer-reviewed evidence.
Its central message is this: Weight centric policies and commissioning are the problem - not individual willpower - and policies and procurement can be changed.
Healthy life expectancy in the UK fell to its lowest level since records began in 2011, standing at 60.7 years for males and 60.9 years for females in 2022 to 2024 - a decline of nearly two years on the previous period (Ref. 50, 2026). In the worst-affected local areas, people are entering ill health in their early fifties, more than a decade before state pension age. The decline occurred in every region and every nation of the UK.
Healthy life expectancy is not a clinical measure. It combines mortality data with a single self-reported survey question about general health. How people answer that question does not exist in a vacuum. It reflects whether they trust the healthcare system enough to engage with it.
It reflects accumulated experiences of being dismissed, or having symptoms attributed to body weight rather than investigated. (Ref. 58, 2022) are direct on this: weight stigma among healthcare providers is linked to healthcare avoidance, under-utilisation of preventive care, and screening - and consistently demonstrates that stigma produces increased allostatic load, higher prevalence of chronic conditions, and further weight gain, independent of BMI.
If stigma is shaping people's relationship with health services, it is also shaping how they answer a question about whether they feel well.
We cannot look at the ONS figures and conclude with confidence how much of the decline in self-reported health reflects worsening physical function, and how much reflects what happens when body weight is treated as a valid proxy for health - over-diagnosed and over-treated (Ref. 29, 2025); (Ref. 48, 2025). That distinction determines whether the right policy response is more weight management or something equitably made different.
There is a further question the data cannot answer. Weight cycling - the repeated pattern of weight loss and recovery generated by the system's own interventions - carries independent cardiovascular consequences including hypertension, insulin resistance, and dyslipidaemia (Ref. 44, 2006). In people with established coronary artery disease, body-weight fluctuation is associated with substantially elevated risks of cardiovascular events and death, independent of traditional risk factors (Ref. 8, 2017); (Ref. 71, 2019). If the people most likely to have engaged with weight management programmes are also the people whose self-reported health has declined most sharply, we should be asking whether the system's own interventions are embedded in these figures. Nobody is asking that question. This strategy does.
The conditions most commonly conflated with higher weight - hypothyroidism, PCOS, obstructive sleep apnoea, depression, osteoarthritis, chronic pain - have their own clinical pathways and will often not resolve with weight loss. Lipoedema, which affects an estimated 10% of women worldwide, does not respond to diet or weight change (Ref. 12, 2025), yet misdiagnosis rates may be as high as 80% (Ref. 45, 2025). Where weight loss is the default clinical response, the diagnostic process stalls. People continue to feel unwell. They rate their health as poor. That response enters the healthy life expectancy calculation.
Meanwhile, the evidence is clear that where a person does not smoke, moderates alcohol, balances nutrition, and moves regularly, all-cause mortality is near-equal across the bodyweight spectrum (Ref. 34, 2012). Health behaviours, sustained, are protective - and almost entirely invisible in a policy framework oriented around weight as the primary outcome measure.
For over sixty years, investment in anti-obesity research and intervention has failed to reduce population weight or improve population health (Ref. 37, 2025). That failure is not a failure of effort or of the people delivering services. It is a failure of framework - one built on the assumption that weight causes poor health, rather than that weight and poor health share common upstream causes rooted in biology, environment, deprivation, and stigma itself (Ref. 61, 2018).
Addressing weight stigma is not a secondary concern alongside declining healthy life expectancy. The evidence suggests it is one of its causes (Ref. 58, 2022); (Ref. 61, 2018); (Ref. 54, 2015). This strategy treats it as such.
The human body has evolved to resist weight loss. When caloric intake is reduced below need, a cascade of biological responses - reduced metabolic rate, increased hunger signalling, altered energy expenditure - work to restore lost weight (Ref. 31, 1995). This is not a failure of willpower. It is physiology. Intentional weight loss attempts produce short-term results in some individuals, followed by weight recovery in the majority, often beyond the starting point (Ref. 33, 2007). The system then asks people to try again. The cycle repeats.
This matters because weight cycling is not neutral. It carries independent cardiovascular risk through hypertension, insulin resistance, and dyslipidaemia (Ref. 44, 2006); (Ref. 71, 2019); (Ref. 8, 2017). A system generating repeated loss-and-recovery cycles in the name of health improvement may be producing the opposite.
The assumption that weight loss drives health improvement is also not well supported by the evidence. In a review of randomised controlled dieting studies with at least one year of follow-up, health improvements were not reliably produced and, where they occurred, were not related to the amount of weight lost - suggesting other factors, principally increases in physical activity, were responsible (Ref. 62, 2013). Surgical removal of fat tissue - liposuction and omentectomy - also fails to deliver metabolic benefit (Ref. 43, 2008); (Ref. 4, 2017), supporting the position that it is beneficial behaviours, not fat reduction, that drives health gain.
BMI compounds these problems as a clinical tool. The best long-term survival outcomes are observed in the so-called "overweight" BMI category (Ref. 19, 2013). Over 30% of adults in the "normal weight" BMI range are metabolically unhealthy, while 29% of adults classified as obese are metabolically healthy (Ref. 63, 2016). BMI does not reliably identify who needs support or what kind. The Lancet Commission (Ref. 29, 2025) and NICE (Ref. 48, 2025) have both concluded that body weight is overdiagnosed and overtreated as a clinical category.
GLP-1 receptor agonists - semaglutide, tirzepatide - are currently being positioned as a solution to what sixty years of intervention has failed to achieve. The evidence does not support that positioning. Cardiovascular benefits are modest and not observed across all demographic groups - data do not support positive effects in women, some ethnic minority groups, or people with a BMI over 35 (Ref. 68, 2025). It is worth noting that weight loss is a side effect of these medications, not their primary clinical purpose - and that the doses used to produce weight loss are higher than those used for their licensed metabolic indications, magnifying associated risks.
Cessation of medication results in rapid weight recovery and reversal of any health benefits accrued (Ref. 11, 2026). Serious adverse effects include acute pancreatitis, gallbladder disease, kidney injury, suicidal ideation, and disruption of absorption of other medications including contraceptives, anticoagulants, and psychotropics (Ref. 41, 2024).
An additional risk is the increased likelihood of restrictive eating disorders - conditions just as dangerous at higher weight as at lower weight, with the highest mortality rate of any psychiatric illness (Ref. 46, 2017).
In the UK, as of April 2026, fatalities and serious reports across the three medications now used for weight loss totalled 88,400 adverse events, 14,138 serious reports, and 200 deaths (Ref. 42, 2026).
The weight-centric model has not failed for lack of trying. It has failed because its foundational premise - that manipulating body weight improves health - is not what the evidence supports. What the evidence supports is that beneficial behaviours, sustained and supported without stigma and weight surveillance, improve health across the entire weight spectrum.
That is the foundation this strategy builds from.
The evidence that beneficial behaviours improve health outcomes across the weight spectrum is substantial, consistent, and largely invisible in current policy design.
(Ref. 34, 2012) followed 11,761 adults across the BMI spectrum for an average of fourteen years. Adherence to beneficial behaviours - not smoking, eating fruit and vegetables, exercising regularly, and moderating alcohol - was associated with significant reductions in all-cause mortality across every BMI category. The greatest absolute benefit was observed in the group classified as "obese". The behaviours are protective regardless of whether they produce weight loss.
(Ref. 28, 2026), using UK Biobank accelerometry data from 59,078 adults, found that modest concurrent improvements in sleep, physical activity, and nutrition were associated with meaningful gains in both lifespan and healthspan. Optimal combined behaviours were associated with 9.35 additional years of lifespan and 9.45 additional years of healthspan. Critically, even small changes delivered meaningful results - an additional five minutes of sleep per day, under two minutes of moderate-to-vigorous physical activity, and half a serving of vegetables produced one additional year of lifespan.
The message is not transformation. It is consistency, and access to the conditions that make consistency possible.
Weight-inclusive interventions - those which do not use weight loss as a goal or outcome measure - consistently deliver equal or better physical and psychological outcomes than weight-focused interventions, with significantly lower dropout rates (Ref. 14, 2024). Improvements include blood pressure, lipid profiles, insulin sensitivity, cardiovascular fitness, mental health, self-esteem, and reduced disordered eating. These gains are sustained after programmes end, where gains from weight-focused comparators typically are not (Ref. 14, 2024); (Ref. 15, 2015); (Ref. 18, 2020).
Lower dropout is not a secondary finding. High attrition is one of the most consistent and least discussed problems in weight-focused services - results are routinely reported only for completers, systematically overstating effectiveness (Ref. 33, 2007); (Ref. 5, 2010). A service that people remain engaged with is categorically more effective than one they leave.
Real-world implementation supports this. NHS Highland has operated a health gains model in its Tier 2 services since 2013, with service evaluation demonstrating significant improvements in diet quality, physical activity, food preoccupation, and mental wellbeing - without weight loss as a target.
Doncaster Council's Compassionate Approach to Weight, now being adopted by councils including Cornwall and Rotherham, similarly focuses on sustained behaviour change over weight loss as the primary success measure (Ref. 17, 2023). The Bristol, North Somerset and South Gloucestershire ICB Why Weight? Pledge commits partner organisations to focusing on the wider determinants of health rather than individual weight (Ref. 9, 2025).
It represents meaningful progress in intent, though project titles such as 'Why Weight?' or 'Weight Wise' still centre weight as the reference point - inadvertently sustaining the signal that weight is where individual failure resides, rather than where systemic change is needed.
The Health at Every Size framework, subject to a 2024 updated systematic review with meta-analysis, was associated with improvements across cardiometabolic markers, eating behaviours, and psychological outcomes (Ref. 14, 2024). The Women and Equalities Committee recommended weight-inclusive models of care including HAES be adopted as national policy in 2021 (Ref. 69, 2021). That recommendation has not yet been acted upon.
The evidence does not suggest that weight is irrelevant to health. It suggests that weight is a poor target for intervention, that the conditions which drive higher weight and poorer health are largely shared, and that addressing those conditions - through behaviour support, stigma reduction, equitable access, and social determinants - produces health gains across the entire weight spectrum. That is what a population health approach requires.
Weight stigma - bias, discrimination, and negative social judgement based on body size - is not a secondary concern in healthcare. It is a structural driver of health inequality with measurable consequences across every clinical setting and every tier of care (Ref. 61, 2018); (Ref. 54, 2015).
It is also not static. Unlike most other forms of implicit bias, which have decreased over time, weight bias has increased (Ref. 10, 2019). It is present in clinicians who are themselves higher weight, and in obesity researchers and specialists (Ref. 64, 2015). It is not a problem of bad people. It is a problem of a system that has trained its workforce to see weight as a clinical target rather than a characteristic.
Higher-weight patients receive shorter consultations (Ref. 60, 2019), less rapport-building from physicians (Ref. 22, 2013), less respect (Ref. 25, 2009), and are assumed to be less adherent to treatment (Ref. 26, 2010). Patients who feel judged about their weight report lower trust in their primary care providers (Ref. 23, 2014). That erosion of trust has direct consequences: it drives avoidance of care, delay in seeking help, and disengagement from services - including cancer screening, maternity care, gynaecological services, and routine chronic condition management (Ref. 2, 2019); (Ref. 3, 2006); (Ref. 39, 2018).
(Ref. 58, 2022): weight stigma in primary care is linked to healthcare avoidance and under-utilisation of preventive services. Patients experiencing weight stigma show higher allostatic load - the cumulative physiological cost of chronic stress - which is itself associated with increased risk of cardiovascular disease, metabolic dysfunction, and premature mortality (Ref. 66, 2017). Stigma does not just feel bad. It produces the conditions it claims to be responding to (Ref. 61, 2018).
In maternity services, a meta-ethnography of 38 studies found that higher-weight pregnant and birthing people experience shame, humiliation, judgement, and blame from healthcare professionals regularly and repeatedly (Ref. 16, 2024). These experiences lead to disengagement from prenatal care, reduced autonomy in birthplace choices, and a pervasive sense of blame that current maternity guidance does not acknowledge or address. The review found that individualised, supportive care from a healthcare professional could alleviate these experiences - pointing clearly to what needs to change, and demonstrating that the capacity for better already exists within the workforce.
In mental health, dual stigma around body size and mental illness deters people from accessing annual health checks and delays eating disorder diagnosis in larger-bodied individuals - a population for whom anorexia nervosa carries the same mortality risk as in any other body (Ref. 46, 2017).
In oncology, fear of judgement is a consistent driver of delayed cancer screening engagement (Ref. 3, 2006). Gynaecological cancer screening engagement is significantly lower in higher-weight women, compounded by the experience of stigma in clinical encounters (Ref. 3, 2006). These are not individual failures of engagement. They are predictable consequences of policies that signal, structurally and explicitly, that higher-weight people must earn access to care.
In physical activity settings, weight-related stigma functions as both a barrier to participation and, for many, a source of trauma (Ref. 6, 2025); (Ref. 70, 2021).
Some of the most significant negative impacts of weight stigma are not interpersonal but structural - embedded in commissioning decisions that use BMI as a criterion for access to care. Higher-weight women face BMI thresholds for NHS-funded IVF that have no robust evidence base and which disproportionately affect women from lower socioeconomic backgrounds (Ref. 47, 2024). BMI-restrictive policies for hip replacement surgery have reduced access without improving outcomes (Ref. 35, 2023).
Weight stigma does not only operate externally. People absorb and apply to themselves the negative messages the system and society transmit about higher-weight bodies - a process known as internalised weight stigma - which is independently associated with poorer mental and physical health outcomes, reduced treatment engagement, and clinical attrition (Ref. 53, 2019); (Ref. 67, 2022). Anti-obesity messaging directed at the general population has been identified as a driver of eating disorder onset (Ref. 40, 2021). The system's communications are not neutral. They have clinical consequences.
Weight stigma does not operate in isolation. It compounds existing inequalities of race, socioeconomic status, gender, and disability - and multiply stigmatised individuals face worse health outcomes across every measure (Ref. 21, 2014); (Ref. 13, 2018). Higher weight is more prevalent in lower socioeconomic groups and some minority ethnic communities, as are upward BMI trajectories (Ref. 1, 2011) - meaning the negative impacts of a weight-centric system fall most heavily on those already carrying the greatest health burden. Any strategy that does not address this intersection is not a health equity strategy.
Weight bias is documented across medicine, nursing, dietetics, exercise science, and allied health professions (Ref. 30, 2021); (Ref. 51, 2018); (Ref. 55, 2014); (Ref. 57, 2012). It is not the fault of individual practitioners. It is the predictable product of training systems, clinical frameworks, and performance measures that have consistently positioned weight as a problem requiring correction. Changing the framework changes what practitioners are asked to do - and the evidence from weight-neutral service models suggests that when that change is made, both staff and patients benefit (Ref. 32, 2021).
The triage / pathway is singular. What varies is the lens, or facets, through which each person's health context is understood. The five facets below are not eligibility categories. They centre health over weight surveillance. Existing clinical safety parameters for medications or surgery would apply.
This framework was designed with the knowledge that the people most likely to need it are those the system has most consistently underserved - people in higher-weight bodies who are disproportionately represented among the most deprived communities, minority ethnic groups, people living with disabilities, and those managing the compounding effects of multiple stigmatised identities.
Rebuilding trust with these communities is not achieved through a renamed service or a redesigned leaflet. It is achieved through the consistent experience, repeated across every encounter and every setting, of a system that responds to health need rather than body size.
Where patients raise weight themselves, staff are equipped - through Nutriri's Weight Neutral Training - with the confidence and skills to respond in a de-stigmatising, honest, and supportive way. That response neither dismisses the person's request nor reinforces weight as a proxy for health. It meets the person where they are, offers honest evidence, and keeps the door open to whatever support they need next.
Trust is not rebuilt through a single redesigned encounter. It is rebuilt through the repeated, consistent experience of a system that does not make its care conditional - on weight, on weight loss, on compliance with a particular intervention, or on any outdated proxy for health. For communities where that trust has been most deeply eroded, only consistency over time will restore it.
This pathway and its facets are designed to deliver exactly that.
Single and multiple long-term conditions are treated on their own clinical merits. Weight is not used as a diagnostic explanation for presenting symptoms - this is consistent with NICE guideline 1.9.1 (Ref. 48, 2025), which explicitly instructs clinicians to avoid attributing symptoms to higher weight and to address the presenting condition directly. Diagnostic overshadowing - the systemic tendency to attribute unrelated symptoms to body size - delays diagnosis, worsens outcomes, and erodes trust that is already fragile in many higher-weight populations.
(Ref. 59, 2026), using longitudinal data from 49.6 million adults in England, found that deprivation and ethnicity are the strongest predictors of MLTC progression. Progression rates were consistently high in the Black ethnic group across all deprivation quintiles, independent of socioeconomic status. These findings have direct implications for where prevention effort should be targeted and how it should be designed. Support under this facet is built around condition clustering and complexity, and explicitly accounts for the compounded barriers faced by people from the most deprived communities and minority ethnic groups - rather than assuming equal starting points.
Beneficial behaviour-based support - encompassing sleep, physical activity, nutrition and stress reduction - is offered as standard alongside condition-specific care, framed as active health-building rather than risk reduction or "weight management". People living with single or multiple long-term conditions stand to gain as much from this support as anyone else on the pathway, and the evidence supports prioritising it early (Ref. 28, 2026); (Ref. 34, 2012).
Eating disorder and disordered eating case finding is a baseline clinical requirement across every facet in this pathway. It is not reserved for people who present with an obvious concern, and it is not optional when someone is pursuing intentional weight change, medications, or bariatric surgery. These are precisely the contexts in which unidentified disordered eating history carries the greatest clinical risk.
Eating disorder and disordered eating history is sensitively asked about at the point of entry to the pathway, and at relevant clinical junctures thereafter, utilising trauma-informed practices. Historical presentations carry the same clinical relevance as current ones. All responses are recorded and carried through the person's care. No weight loss attempt, no weight-loss medications referral, and no bariatric pathway proceeds without completed eating disorder screening and, where indicated, specialist oversight.
Anorexia nervosa carries the highest mortality rate of any psychiatric illness and is equally dangerous in higher-weight as in lower-weight individuals (Ref. 46, 2017). Anti-obesity messaging and weight-focused clinical encounters have been identified as drivers of eating disorder onset (Ref. 40, 2021). A weight-neutral pathway reduces this risk structurally - by removing the conditions under which disordered eating is most likely to be missed, minimised, or inadvertently reinforced.
A person's plan to attempt weight change (Unmedicated / Non-Surgical) is met without stigma, without the withdrawal of any other care, and without the system substituting its own judgement for theirs. Body autonomy is fully respected and met with compassion.
What the system provides alongside that respect, as a matter of informed consent with ANY attempt at weight change - Facets 3,4 and 5 - is honest evidence - about the long-term outcomes of intentional weight change, about the biological mechanisms that drive weight recovery, and about the cardiovascular risks associated with weight cycling (Ref. 44, 2006); (Ref. 71, 2019); (Ref. 8, 2017).
Eating disorder and disordered eating screening, as described in Facet 2, is completed before any intentional weight change support is initiated. Weight loss intention does not alter entitlement to the full range of health support available to everyone else on this pathway. If weight loss attempts are unsuccessful or abandoned, the person remains in the pathway, supported, without having to re-earn access or re-justify their presence.
Declining or being unable to use weight-loss medications does not deprioritise access to any other facet of this pathway. This must be explicit in both commissioning policy and individual clinical encounters - not assumed, not implied, but stated. Full beneficial behaviour-based and condition-specific support is available regardless of medication status.
Where someone does engage with medications, robust informed consent is required. That process must include honest evidence on typical long-term weight outcomes, the pattern of weight recovery on cessation, the higher doses used to produce weight loss as a side effect and the magnified risk profile those doses carry, potential interactions with other medications including contraceptives, anticoagulants, and psychotropics, and the UK adverse event data: as of April 2026, three medications used for weight loss had generated 88,400 adverse events, 14,138 serious reports, and 200 deaths (Ref. 42, 2026). Support does not end when medication is stopped and weight is regained. The person remains in the pathway without penalty.
Eating disorder and disordered eating screening, as described in Facet 2, is completed before medications are initiated. The appetite-suppressive mechanism of these drugs carries specific risks for people with restrictive eating histories, and this must be assessed and recorded prior to prescribing.
Weight-neutral nutritional and psychological support is embedded as standard both before and after bariatric surgery. Surgery does not resolve weight stigma, disordered eating, or the social determinants that shape a person's health. A post-operative patient carries exactly the same entitlement to full weight-neutral health support as anyone else on this pathway, for as long as they need it.
Sensitive eating disorder and disordered eating screening, as described in Facet 2, is completed as part of the pre-operative process and revisited post-operatively. The structural changes produced by bariatric surgery alter the relationship between eating behaviour, hunger signalling, and nutritional absorption in ways that require ongoing, informed, weight-neutral support.
Support under this facet is explicitly non-linear. Someone may pursue surgery, step back, re-engage, or move between facets at any point. The pathway accommodates all of this without penalty and without requiring the person to re-present from the beginning.
Support does not end when weight recovery happens post surgery. The person remains in the pathway without penalty. Quality standards should include preparing for weight recovery to avoid internalised stigma disengaging an individual through their felt sense of 'failure'. Managing expectations should be standard as part of robust informed consent alongside honest short and long term risks profiles for their chosen surgery type.
The shift from a weight-centric to a health-centred system requires a parallel shift in what is measured, what is reported, and what commissioners and providers are held accountable for. Outcome measures shape behaviour. If the measure is weight, the system pursues weight. If the measure is health, the system pursues health.
The following are the domains this strategy proposes as the basis for measuring the effectiveness of weight-neutral health services. They are not exhaustive, and local implementation should involve co-production with communities and local systems to ensure measures are meaningful, accessible, and reflective of what people actually experience.
Engagement in beneficial health behaviours - sleep duration and quality, physical activity frequency and enjoyment, food access, diet quality and eating regularity - assessed using validated, non-stigmatising tools. The evidence is clear that modest, sustained improvements in these behaviours are associated with meaningful gains in lifespan and healthspan across the weight spectrum (Ref. 28, 2026); (Ref. 34, 2012). Equitable food access is a structural determinant of these behaviours, not an individual choice - and outcome measurement must account for the environments in which people are attempting to sustain them. A person cannot be held to a nutritional behaviour outcome that their income, geography, or food environment does not support. These structural factors must be captured alongside individual behavioural data.
Blood pressure, HbA1c, lipid profiles, inflammatory markers, cardiorespiratory fitness, and condition-specific indicators relevant to the person's clinical context. These are the measures that reflect actual health status, that respond to behaviour change, and that predict future health outcomes. They are also the measures most likely to demonstrate improvement in a weight-neutral service - and most likely to be obscured when weight is used as the primary outcome.
Depression and anxiety symptomology, self-esteem, body satisfaction, eating disorder symptomology, quality of life, and social connectedness. These outcomes matter intrinsically, and they are also clinically significant - body dissatisfaction and weight stigma internalisation are independently associated with poorer physical health outcomes, reduced treatment engagement, and clinical attrition (Ref. 53, 2019); (Ref. 61, 2018). A service that improves psychosocial wellbeing is a service that improves long-term health engagement.
Healthcare avoidance rates, appointment attendance, screening uptake, patient-reported experience of stigma in clinical encounters, and trust in services - measured across the weight spectrum and disaggregated by deprivation, ethnicity, gender, and disability. These measures capture what the current system systematically fails to track: whether people are actually engaging, and whether their experience of doing so is one that helps create more collaborative clinicians and patients.
Dropout and attrition rates are among the most important and least reported indicators of service effectiveness. Weight-inclusive services consistently demonstrate significantly lower attrition than weight-focused comparators (Ref. 14, 2024). A service that people remain engaged with delivers more health gain per pound spent than one they leave. Retention should be a primary, not secondary, performance indicator.
Weight loss. BMI reduction. Achievement of a "healthy weight" band. These are not health outcomes. They are not reliable proxies for health outcomes. Their use as performance indicators has actively distorted service design, driven inappropriate interventions, and produced the attrition, weight cycling, and erosion of trust this strategy is designed to address. Removing them from the outcome framework is not a lowering of ambition. It is a raising of it.
A weight-neutral health system does not require new buildings, new budgets or the wholesale dismantling of existing services. It requires a reorientation of what existing services are for, what they measure, and how the people working within them are supported to deliver healthcare differently. Much of what needs to change is structural signalling - the frameworks, language, thresholds, and performance measures that currently misdirect staff and patients to regard weight as a proxy for health.
BMI thresholds must be removed from all access criteria across NHS and publicly funded health services. The evidence that BMI-gating improves outcomes is absent; the evidence that it produces inequitable access, delayed diagnosis, and erosion of trust is substantial (Ref. 35, 2023); (Ref. 47, 2024); (Ref. 54, 2015). "Weight management" services should be reframed as weight-neutral health promotion services, with referral based on health need and sustaining beneficial behaviours rather than BMI. Commissioning outcomes should reflect the measurement framework set out in Section 6 - behavioural, clinical, psychosocial, and engagement-based - with body weight and composition explicitly removed as key performance indicators.
Existing budgets, including those currently allocated to programmes such as the National Child Measurement Programme, should be reviewed for reallocation toward stigma-informed health promotion, body image education in schools, and weight-neutral community health services. The NCMP does not deliver health improvement and is associated with increased maladaptive behaviours over time (Ref. 68, 2025). Repurposing those resources toward what the evidence supports is not a reduction in investment in children's health - it is an improvement in its quality.
Weight stigma and bias training must become a baseline requirement across all health and social care roles - clinical and non-clinical. That training must go beyond awareness-raising to deliver the practical skills and confidence that allow staff to engage with higher-weight patients without defaulting to weight as a clinical target.
Nutriri's Weight Neutral Training, developed over a decade alongside people with lived experience of weight stigma, provides a practical, evidence-based framework for this shift across community, healthcare, workplace, and family settings.
Training should specifically address: recognising and interrupting diagnostic overshadowing; conducting trauma-informed eating disorder and disordered eating case finding; communicating honest evidence about weight and health without stigma; and supporting patients who raise weight themselves in a de-stigmatising and autonomy-respecting way. This is not an additional burden on an already stretched workforce. It is equipping people to do more effectively what they are already trying to do - elevate health outcomes.
The language used across all health services, communications, and policies must be reviewed and updated. This includes removal of terms such as "weight management", "healthy weight", "obesity prevention", and "anti-obesity" from service titles, referral pathways, patient-facing communications, and clinical guidelines where they function to stigmatise rather than inform. Person-first language, while well-intentioned, continues to centre weight as a defining characteristic - the shift required is away from weight as a reference point entirely, not simply a repositioning of where it sits in a sentence.
Weight-neutral language is not euphemism. It is clinical precision - reflecting what the evidence actually supports about the relationship between weight, stigma, behaviour, and health.
Every clinical and community health setting should ensure appropriately sized equipment, seating, gowns, blood pressure cuffs, and examination facilities are available as standard - not kept in a separate room or requested in advance. The physical environment communicates, before a word is spoken, whether a person is expected and welcome. For higher-weight people with existing experience of stigma in healthcare, an environment that has not accounted for their body is one that confirms what they feared.
Weight is not currently a protected characteristic under the Equality Act 2010 (Ref. 38, 2021). Given the substantial and growing evidence that weight-based discrimination produces measurable negative impacts on health, healthcare access, employment, and quality of life - and that it compounds existing protected characteristics including race, sex, and disability - this gap in legislative protection should be addressed. This strategy calls for weight to be included as a protected characteristic in equality legislation across the UK.
BMI-restrictive policies across all publicly funded services should be reviewed, with a presumption toward removal where the evidence base for restriction is absent or weak. Any policy that uses BMI as an access criterion should be required to demonstrate clinical justification and equity impact assessment before it is maintained or introduced.
Ring-fenced funding is needed for weight-neutral and weight-inclusive research at scale - larger trials, longer follow-up periods, and evaluation of real-world implementation across diverse communities (Ref. 68, 2025). The current research funding landscape disproportionately supports weight-loss interventions, reflecting commercial interest as much as clinical priority. WINN UK, established in 2025 and led by researchers at UWE Bristol and the University of Essex, exists to generate this evidence in response to the needs of practitioners and communities. Nutriri's training and workforce development work sits alongside and feeds into this research infrastructure.
Evaluation of weight-neutral services should use the measurement framework set out in Section 6, with data disaggregated by deprivation, ethnicity, gender, disability, and other relevant characteristics - so that equity of impact, not just average outcomes, is visible and accountable.
The economic argument for a weight-neutral health system is not separate from the ethical one. They point in the same direction.
Nutriri's analysis of publicly funded weight management commissioning between November 2022 and November 2023 identified contract values totalling hundreds of millions of pounds allocated to services operating on a weight-centric model (Ref. 27, 2023). These services are not delivering the outcomes their commissioning frameworks require - because, as Section 2 sets out, the biological evidence does not support the premise they are built on. Spending public money on interventions that the evidence does not support, that produce high attrition, and that generate weight cycling with its associated cardiovascular risks, is neither economically nor ethically defensible.
Restricting access to hip replacement surgery by BMI threshold does not improve surgical outcomes and generates downstream costs through delayed and worsened presentations (Ref. 35, 2023). A systematic review and meta-analysis found low-quality evidence that weight-loss diets before elective surgery do not reduce postoperative complications or length of stay - yet health professionals continue to recommend preoperative weight loss for higher-weight patients as standard practice, without adequate evidence to support doing so (Ref. 52, 2021). BMI thresholds for NHS-funded IVF disproportionately affect women from lower socioeconomic backgrounds, producing inequitable outcomes at public expense (Ref. 47, 2024). Across every setting where BMI is used as an access criterion without robust clinical justification, the system is producing avoidable cost - in delayed diagnosis, worsened conditions, increased emergency presentation, and the long-term burden of undertreated chronic disease.
Weight stigma produces measurable economic consequences. Healthcare avoidance driven by anticipated or experienced stigma results in later, more complex, and more expensive presentations (Ref. 2, 2019); (Ref. 39, 2018). Diagnostic overshadowing means conditions go unidentified and untreated until they become acute. Shorter consultations, reduced rapport, and lower trust produce lower treatment adherence and poorer outcomes (Ref. 22, 2013); (Ref. 26, 2010). Each of these represents avoidable cost to the system - cost generated not by the patient's body but by the system's response to it.
Weight stigma also carries costs beyond the health system. In workplace settings, higher-weight employees face discrimination in hiring, pay, and progression (Ref. 56, 2006). The productivity, absence, and mental health consequences of that discrimination have economic impacts that extend well beyond the NHS. Nutriri's weight stigma training in workplace settings addresses this directly, creating conditions where health - rather than body size - is the basis on which people are supported.
Weight-inclusive services demonstrate significantly lower dropout than weight-focused comparators (Ref. 14, 2024). Lower attrition means more health gain delivered per pound of commissioning spend. Health gains are sustained after programmes end, where weight-focused comparators typically reverse (Ref. 14, 2024); (Ref. 15, 2015). Improvements in clinical markers, psychosocial wellbeing, and healthcare engagement reduce downstream demand - on primary care, secondary care, mental health services, and emergency settings.
The NHS Highlands health gains model, operating since 2013, demonstrates that reorienting existing services toward health outcomes rather than weight loss produces sustained improvements without additional resource. This is not a case for more spending. It is a case for different spending - redirecting existing investment toward what the evidence supports.
People in higher-weight bodies are entitled to the same standard of healthcare as anyone else. That entitlement is currently compromised by stigma, by BMI-gating, by diagnostic overshadowing, by shorter consultations, by physical environments that have not accounted for their bodies, and by a system of performance measures that has made weight loss - rather than health - the definition of success. This is not a matter of competing priorities or resource constraints. It is a matter of whether the NHS delivers on its founding principle of care based on need.
Weight stigma compounds existing inequalities of deprivation, ethnicity, gender, and disability - meaning its negative impacts fall most heavily on the communities the system has the greatest obligation to serve equitably (Ref. 61, 2018); (Ref. 54, 2015); (Ref. 1, 2011). A system that generates and sustains those inequalities through its own design is one that has both the capacity and the responsibility to change.
The Higher Weight Health Strategy does not ask the government to spend more. It asks it to spend differently, measure differently, and signal differently - so that the brilliant people already working within healthcare systems are freed to deliver the health equity its founding principles have always promised.
The evidence base underpinning this strategy has been built over more than a decade of direct engagement with citizens, patients, carers, and healthcare professionals across the UK. It has been gathered through Nutriri's training and consultancy work in community, healthcare, workplace, and family settings - through conversations that the formal research literature does not always capture, and through the consistent patterns that emerge when people who have been failed by a weight-centric system are finally asked what they actually need.
One documented example of that engagement was Nutriri's contribution to the NHS 10 Year Health Plan consultation - the national Create an NHS Fit for the Future event - held on 5th February 2025. Nutriri hosted a Workshop in a Box session, actively recruiting a diverse group including research fellows, academics, people with lived experience, clinicians, VCSE colleagues, ICS representatives, and Core20PLUS5 Ambassadors. The session focused on the third shift of the 10 Year Health Plan - preventing sickness, not just treating it - examined through a weight-neutral lens.
What follows is not a complete record of that session or of the decade of engagement it represents. It is a distillation of the themes that have emerged consistently, across settings and across years, from people who understand from the inside what a weight-centric system does - and what a different one could look like.
Asked to describe in three words how using the NHS would feel if the 10 Year Health Plan succeeded, participants reached for the same territory regardless of background or role: safe, non-judgemental, inclusive, compassionate, stigma-free, trusting, supported.
The gap between those words and the current experience of many higher-weight people in healthcare is the product of a system designed around the wrong signal. Changing the signal is what closes the gap.
The most consistent theme across every engagement Nutriri has conducted is this: people do not want to be reduced to their body weight. They want their health concerns heard, investigated, and addressed. They want to access care without bracing for a conversation about their body size that has nothing to do with why they came. They want healthcare professionals who see them as whole people - and the healthcare professionals themselves, in many shared conversations, have said the same thing. They want to be able to do that too. The system has not always let them.
The shift from health equals weight to health equals health is not complex. It does not require new science. It requires the system to act on the science it already has.
Participants across engagements identified diagnostic overshadowing as one of the most significant and consistent negative impacts of the current system - the experience of presenting with a health concern and having it attributed to weight rather than investigated. The call was clear: address the presenting condition. Ask about the person's experience. Do not assume that weight is the explanation, the cause, or the solution.
Conditions like type 2 diabetes and osteoarthritis were specifically identified as needing reframing - away from the assumption that they are driven by weight, and toward the underlying factors including inflammation, chronic stress, poor sleep, environmental exposures, genetics, and socioeconomic circumstance. Intersectionality was named explicitly: the combination of complex factors people face requires support that is genuinely tailored, not a one-size pathway built without them.
The call from practitioners and citizens alike was not for more dietary advice. It was for health literacy and nutritional support that begins with sufficiency - ensuring people are eating regularly and adequately - before layering any further guidance. Restrictive approaches were consistently identified as counterproductive, driving the bingeing, shame, and metabolic disruption that perpetuate the very patterns the system is trying to address.
Equitable food access was named as a structural priority, not an individual responsibility. A decolonial lens was called for in addressing the deep roots of oppression that shape food access and culture. Commercial interests - pharmaceutical companies, diet industry, food manufacturers - sponsoring clinical training and conferences was specifically raised as a concern requiring active resistance.
The nutrition conversation also surfaced the non-linear nature of support needs: a post-operative bariatric patient still needs nutrition support and size acceptance. Someone who has stopped medications and experienced weight recovery needs a shame-free structure around them. Support does not end at a clinical milestone.
Across every engagement, the call was to decouple exercise from weight loss - not just in language but in the active, explicit framing of physical activity as beneficial regardless of any effect on body size or composition. Intrinsic motivation, exercise as enjoyment, and movement as a source of strength and function rather than a tool for appearance change were consistently identified as the conditions under which people actually sustain physical activity long-term.
Representation matters here. The near-total absence of larger bodies in exercise promotion materials was raised repeatedly as a signal - one that tells higher-weight people that movement is not for them. That signal needs to change.
Safe spaces, affordability, and genuinely inclusive environments were raised as structural requirements, not optional additions. Weight stigma in physical activity settings is documented as functioning as both a barrier to participation and, for many, a source of trauma (Ref. 6, 2025). Inclusive training curricula for sport and exercise professionals, PE teachers, and fitness providers were identified as an urgent workforce development need.
The thread running through every engagement, every workshop, and every conversation Nutriri has had over a decade is this: the problem is not the people in higher-weight bodies. It is not the healthcare professionals trying to support them. It is the framework within which both are operating - one that has consistently located the problem in the individual body rather than in the systems, environments, and structural inequalities that shape us.
When the system changes its behaviour, people's relationship with healthcare changes too. That is not a theory. It is what Nutriri has observed, consistently, over ten years of working directly with people failed by a weight-centric system. A stigma-informed system does not just remove barriers - it actively builds the conditions for people to engage, contribute, and trust that their experience of their own body will be heard rather than overridden.
That is what this strategy is working toward. And it is entirely within reach.
The following recommendations are directed at four audiences: commissioners and policymakers, clinical and service leads, workforce training leads, and government. They are presented as actionable, sequenced priorities rather than aspirational statements.
Remove BMI and weight thresholds from all access criteria across NHS and publicly funded health services, with immediate review of existing BMI-gated policies including IVF, hip replacement, and elective surgery pathways. Any policy retaining a BMI criterion must demonstrate robust clinical justification and a completed equity impact assessment.
Reframe all "weight management" services as weight-neutral health promotion services. Referral criteria should be based on health needs and sustaining beneficial behaviours. BMI and body composition must be removed as key performance indicators.
Adopt the measurement framework set out in Section 6 of this strategy - behavioural, clinical, psychosocial, and engagement-based outcomes - as the basis for commissioning, contract monitoring, and service evaluation. Weight loss and BMI reduction are not health outcomes and should not be commissioned as such.
Review and reallocate budgets currently funding ineffective weight-centric programmes, including the National Child Measurement Programme, toward stigma-informed health promotion, body image education in schools, and weight-neutral community health services.
Establish funded partnerships between weight-neutral VCSE organisations, Local Authority and NHS commissioners to co-produce and co-deliver services. Nutriri's Weight Neutral Training and the five-facet pathway framework set out in this strategy provide a practical starting point for these partnerships.
Require that all commissioned health services demonstrate equitable access across the weight spectrum, with outcome data disaggregated by deprivation, ethnicity, gender, and disability. Equity of impact, not just average outcomes, must be visible and accountable.
Ring-fence research funding for weight-neutral and weight-inclusive approaches at sufficient scale to enable larger trials, longer follow-up periods, and real-world implementation evaluation across diverse communities.
Implement the five-facet weight-neutral triage pathway set out in Section 5 as the operational framework for all services engaging with higher-weight populations. No facet operates in isolation - all five are held simultaneously by trained staff.
Embed eating disorder and disordered eating case finding, using trauma-informed practices, as a baseline clinical requirement across all facets/pathways.
Remove diagnostic overshadowing from clinical practice by implementing NICE guideline 1.9.1 (Ref. 48, 2025) as a standard of care: presenting conditions are addressed on their own clinical merits. Weight is not a diagnosis.
Ensure robust informed consent processes for intentional weight change, medications or surgery, including honest evidence on typical long-term outcomes, weight recovery on cessation, adverse effect profile, medication interactions, and UK adverse event data (Ref. 42, 2026).
Embed weight-neutral nutritional and psychological support as standard pre- and post-operatively for bariatric surgery patients, with indefinite follow-up.
Audit the physical environment of all clinical and community health settings to ensure appropriately sized equipment, seating, gowns, and examination facilities are available as standard - not on request.
Measure and report service retention and attrition rates as primary performance indicators. A service that people leave is not a service that is working.
Commission Nutriri's Weight Neutral Training as a baseline requirement across all health and social care roles - clinical and non-clinical - with particular priority given to primary care, maternity services, mental health, long-term conditions management, and physical activity provision.
Ensure training addresses the practical skills required by this strategy: recognising and interrupting diagnostic overshadowing; conducting trauma-informed eating disorder case finding; communicating honest evidence about health without stigma; and supporting patients who raise weight themselves in a de-stigmatising and autonomy-respecting way.
Extend weight stigma and bias training to sport and exercise science curricula, PE teacher training, and fitness professional certification programmes. Inclusive training curricula should be standardised across all physical activity settings.
Resist and actively discourage the sponsorship of clinical continuing professional development by pharmaceutical companies, diet industry organisations, and food manufacturers whose commercial interests conflict with weight-neutral health promotion.
Reframe the national obesity strategy as a higher weight health strategy, shifting the policy goal from weight reduction to health improvement across the weight spectrum. Remove obesity framing from existing and future policy documents.
Include weight as a protected characteristic in the Equality Act 2010 and equivalent legislation across devolved nations. The evidence that weight-based discrimination produces measurable negative impacts on health, employment, and quality of life - and that it compounds existing protected characteristics - is now substantial (Ref. 38, 2021).
Direct NICE to review and update Quality Standards to measure health outcomes rather than weight outcomes, and to remove weight loss as an indicator of clinical success across all relevant guidelines.
Fund weight neutral / inclusive researchers to conduct the systematic research needed to evaluate the scope, effectiveness, and cost-efficiency of weight-neutral and weight-inclusive approaches across UK health and care settings.
Acknowledge, at policy level, that the pursuit of anti-obesity strategies focused on individual behaviour change has not reduced population weight, has not improved population health, and has compounded health inequalities for over sixty years. A different approach is not a political risk. It is a public health necessity.
These recommendations are grounded in the evidence presented across this strategy, and are deliverable within existing structures and budgets.
The question is not whether this is possible. It is whether the system is ready to act on what it already knows.
Email us to ask for our reference list to be shared - thank you.
The list consists of 71 references spanning 1995 - 2026.
Nutriri received no funding to create this draft strategy or for the decade's worth of gathering lived experiences that preceded this.
Get in touch if you'd like to support patient innovation.
This is your invitation to contribute to this strategy, an informal consultation project to surface tensions and disconnects, as well as connections and co-development opportunities.